Carboxylated Mannan Coating for MRI Contrast Agent Stability
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing MRI contrast agents, particularly superparamagnetic iron oxide nanoparticles, face issues with toxicity, stability, and specificity in targeting antigen presenting cells, leading to suboptimal diagnostic capabilities for conditions like cancer and sepsis.
Innovation Solution
A superparamagnetic MRI contrast agent coated with carboxylated mannan is developed, which enhances in vivo stability and biocompatibility, allowing specific targeting and visualization of antigen presenting cells through the introduction of a carboxyl group into mannan, improving the agent's ability to be introduced into these cells.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If pure superparamagnetic iron oxide particles are used as MRI contrast agents, then high sensitivity and μM level imaging capability are achieved, but toxicity increases and in vivo stability decreases
Solution Approach 1:
Mannan acts as an intermediary coating material between the superparamagnetic iron oxide particles and the biological environment. The mannan coating provides a biocompatible interface that reduces direct contact between toxic iron oxide and biological tissues, while maintaining the magnetic properties needed for high-sensitivity imaging at μM levels.
Solution Approach 2:
The contrast agent is formulated as a composite material combining superparamagnetic iron oxide particles with mannan coating. This composite structure integrates the high magnetic sensitivity of iron oxide with the biocompatibility and stability of mannan, simultaneously achieving both imaging sensitivity and reduced toxicity.
2Volume of moving object
If pure superparamagnetic iron oxide particles are used, then high volume-to-surface area ratio is achieved, but hydrophobic interaction and coagulation increase forming clusters
Solution Approach 1:
Mannan serves as a stabilizing intermediary layer on the particle surface that prevents direct hydrophobic interactions between iron oxide particles. This coating layer provides steric stabilization that maintains colloidal stability and prevents coagulation and clustering, allowing the particles to remain dispersed in physiological environments.
3Stability of the object's composition
If conventional coating materials like dextran or synthetic polymers are used, then stability is improved, but specificity in targeting antigen presenting cells is reduced
Solution Approach 1:
The mannan coating provides localized functional properties that differ from conventional coatings. Specifically, mannan contains mannose residues that can interact with mannose receptors on antigen-presenting cells, providing localized targeting functionality at the particle surface while maintaining overall colloidal stability in circulation.
4Adaptability or versatility
If mannan is used for coating, then targeting ability is improved, but biotoxicity and circulation trapping increase
Solution Approach 1:
The physical and chemical parameters of the mannan coating are optimized to balance targeting ability with reduced toxicity. By controlling the degree of carboxymethylation and molecular weight of mannan, the coating maintains sufficient mannose residues for receptor targeting while modifying the overall surface chemistry to reduce biotoxicity and improve circulation half-life.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The carboxylated mannan-coated superparamagnetic nanoparticles demonstrate improved stability, reduced toxicity, and enhanced contrast-enhancement ability for antigen presenting cells, facilitating early diagnosis of cancer metastasis and sepsis with improved spatial resolution and reduced radiation risk compared to conventional methods.
Implementation Method 1
The pure superparamagnetic iron oxide particle (1) is hydrophobic and shows the high ratio of volume to surface area, suggesting the strong hydrophobic interaction and coagulation that can form a cluster easily
Implementation Method 2
The pure superparamagnetic iron oxide particle (1) is hydrophobic and shows the high ratio of volume to surface area, suggesting the strong hydrophobic interaction and coagulation that can form a cluster easily
Implementation Method 3
MRI contrast agents are divided into two groups: paramagnetic contrast agents and superparamagnetic contrast agents. The superparamagnetic contrast agent widely used in clinical is prepared by using superparamagnetic nanoparticles represented by such superparamagnetic iron oxide (SPIO) as magnetite (Fe3O4) and maghemite (Fe2O3). These agents alter the T1 and T2 relaxation times of tissues and body cavities where they are present
Data Source
AI summary
The present invention relates to a magnetic resonance imaging (MRI) contrast agent coated with carboxylated mannan, particularly a carboxylated mannan coated superparamagnetic MRI contrast agent specifically targeting antigen presenting cells and having excellent in vivo stability, and a method for producing the same. The MRI contrast agent coated with carboxylated mannan of the present invention can provide excellent in vivo stability and biocompatibility owing to its high surface negative charge, and can be introduced specifically into antigen presenting cells owing to mannose of mannan, so as to visualize the antigen presenting cells and the tissue containing the antigen presenting cells in MRI.